Heron Therapeutics (HRTX) EBIT (QoQ) (2010 - 2026)
Heron Therapeutics (HRTX) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Heron Therapeutics |
85.57 Mn |
55.60 Mn |
24.07 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-12,639.47% |
| Dec 31, 2025 |
100.93% |
| Sep 30, 2025 |
-150.03% |
| Jun 30, 2025 |
-151.90% |
| Mar 31, 2025 |
-24.42% |
| Dec 31, 2024 |
193.61% |
| Sep 30, 2024 |
30.83% |
| Jun 30, 2024 |
-34.33% |
| Mar 31, 2024 |
53.05% |
| Dec 31, 2023 |
59.00% |
| Sep 30, 2023 |
41.21% |
| Jun 30, 2023 |
-28.25% |
| Mar 31, 2023 |
-62.43% |
| Dec 31, 2022 |
51.40% |
| Sep 30, 2022 |
15.39% |
| Jun 30, 2022 |
21.34% |
| Mar 31, 2022 |
-17.53% |
| Dec 31, 2021 |
-3.54% |
| Sep 30, 2021 |
14.49% |
| Jun 30, 2021 |
-16.03% |
